2.33
price up icon1.30%   0.03
after-market After Hours: 2.28 -0.05 -2.15%
loading
Mereo Biopharma Group Plc Adr stock is traded at $2.33, with a volume of 3.57M. It is up +1.30% in the last 24 hours and down -2.10% over the past month. Mereo BioPharma Group PLC is a United Kingdom (U.K.) based biopharmaceutical company focused on the development of therapeutics for rare diseases. The company has developed a portfolio of late-stage clinical product candidates, and its two rare disease product candidates are setrusumab for the treatment of osteogenesis imperfecta (OI) and alvelestat primarily for the treatment of severe alpha-1 antitrypsin deficiency-associated lung disease (AATD-LD).
See More
Previous Close:
$2.30
Open:
$2.3
24h Volume:
3.57M
Relative Volume:
2.69
Market Cap:
$302.10M
Revenue:
$10.00M
Net Income/Loss:
$-29.47M
P/E Ratio:
-11.65
EPS:
-0.2
Net Cash Flow:
$-21.55M
1W Performance:
+22.63%
1M Performance:
-2.10%
6M Performance:
-48.57%
1Y Performance:
-11.74%
1-Day Range:
Value
$2.2596
$2.42
1-Week Range:
Value
$1.89
$2.42
52-Week Range:
Value
$1.575
$5.02

Mereo Biopharma Group Plc Adr Stock (MREO) Company Profile

Name
Name
Mereo Biopharma Group Plc Adr
Name
Phone
4403330237300
Name
Address
ONE CAVENDISH PLACE, LONDON
Name
Employee
36
Name
Twitter
@MereoBioPharma
Name
Next Earnings Date
2025-03-26
Name
Latest SEC Filings
Name
MREO's Discussions on Twitter

Compare MREO with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
MREO
Mereo Biopharma Group Plc Adr
2.33 302.10M 10.00M -29.47M -21.55M -0.20
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
477.52 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.49 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
595.70 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
232.75 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
229.22 26.16B 3.81B -644.79M -669.77M -6.24

Mereo Biopharma Group Plc Adr Stock (MREO) Upgrades & Downgrades

Date Action Analyst Rating Change
Mar-27-25 Initiated JP Morgan Overweight
Dec-06-24 Initiated Jefferies Buy
Jun-13-24 Initiated Robert W. Baird Outperform
Oct-13-23 Resumed BTIG Research Buy
Aug-12-22 Initiated Cantor Fitzgerald Overweight
May-05-21 Initiated BTIG Research Buy
Apr-05-21 Initiated Needham Buy
View All

Mereo Biopharma Group Plc Adr Stock (MREO) Latest News

pulisher
Apr 08, 2025

There is no way Allarity Therapeutics Inc (ALLR) can keep these numbers up - Sete News

Apr 08, 2025
pulisher
Apr 04, 2025

Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges By Investing.com - Investing.com South Africa

Apr 04, 2025
pulisher
Apr 04, 2025

Mereo BioPharma stock hits 52-week low at $2.1 amid market challenges - Investing.com India

Apr 04, 2025
pulisher
Apr 03, 2025

C3is Inc Inc. (CISS) Price Performance Over the Years: A Comparative Study - investchronicle.com

Apr 03, 2025
pulisher
Apr 01, 2025

Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough - Investing.com India

Apr 01, 2025
pulisher
Mar 31, 2025

Mereo BioPharma’s SWOT analysis: rare disease stock poised for breakthrough By Investing.com - Investing.com South Africa

Mar 31, 2025
pulisher
Mar 26, 2025

Mereo BioPharma stock hits 52-week low at $2.25 - Investing.com India

Mar 26, 2025
pulisher
Mar 26, 2025

Mereo BioPharma Reports Full Year 2024 Financial Results and Provides Corporate Highlights - GlobeNewswire

Mar 26, 2025
pulisher
Mar 26, 2025

Mereo BioPharma Secures 3-Year Cash Runway While Pushing Phase 3 Studies Forward - Stock Titan

Mar 26, 2025
pulisher
Mar 26, 2025

Closing Bell Recap: WANG & LEE Group Inc (WLGS) Ends at 0.43, Reflecting a -42.70 Downturn - The Dwinnex

Mar 26, 2025
pulisher
Mar 21, 2025

Pfizer to Exit Sensodyne-Maker Haleon With Final Stake Sale - MSN

Mar 21, 2025
pulisher
Mar 21, 2025

MEREO BIOPHARMA (MREO) Upgraded to Buy: What Does It Mean for the Stock? - MSN

Mar 21, 2025
pulisher
Mar 20, 2025

ARS Pharmaceuticals outlines 2025 growth strategy with neffy commercialization and global expansion - MSN

Mar 20, 2025
pulisher
Mar 19, 2025

Mereo BioPharma’s SWOT analysis: setrusumab, alvelestat drive rare disease stock potential - Investing.com India

Mar 19, 2025
pulisher
Mar 11, 2025

Hidden Gems: 5 Stocks Under $10 With Massive Growth Potential - Barchart

Mar 11, 2025
pulisher
Feb 26, 2025

How Do Things Look For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) In The Short-Term? - Stocks Register

Feb 26, 2025
pulisher
Feb 25, 2025

Mereo BioPharma stock hits 52-week low at $2.52 By Investing.com - Investing.com South Africa

Feb 25, 2025
pulisher
Feb 25, 2025

Mereo BioPharma stock hits 52-week low at $2.52 - Investing.com India

Feb 25, 2025
pulisher
Feb 06, 2025

Prepare Yourself for Liftoff: Mereo Biopharma Group Plc ADR (MREO) - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

There is no doubt that OrganiGram Holdings Inc (OGI) ticks all the boxes. - SETE News

Feb 06, 2025
pulisher
Feb 06, 2025

Check Out ImmunoPrecise Antibodies Ltd (IPA)’s Trade Data Rather Than the Analysts’ Views - SETE News

Feb 06, 2025
pulisher
Feb 04, 2025

Recent Insider Activity Could Benefit Mereo Biopharma Group Plc ADR (MREO) - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Analyzing Digital Turbine Inc (APPS) After Recent Trading Activity - Knox Daily

Feb 04, 2025
pulisher
Feb 04, 2025

Market Insights: Mereo Biopharma Group Plc ADR (MREO)’s Notable Drop of -0.66, Closing at 2.99 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

Daily Market Movement: Twist Bioscience Corp (TWST) Sees a 0.73 Increase, Closing at 52.75 - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

In the Green: Sensata Technologies Holding Plc (ST) Closes at 25.62, Up/Down -5.67 from Previous Day - The Dwinnex

Feb 04, 2025
pulisher
Feb 04, 2025

How should investors view Anavex Life Sciences Corporation (AVXL)? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Health In Tech Inc (HIT) is an excellent investment, but the stock is overvalued/undervalued right now - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Was there any good news for Mereo Biopharma Group Plc ADR (MREO) stock in the last session? - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

It would be worthwhile to take a closer look at Therealreal Inc (REAL) - US Post News

Feb 04, 2025
pulisher
Feb 04, 2025

Lemonade Inc (LMND) deserves deeper analysis - US Post News

Feb 04, 2025
pulisher
Jan 22, 2025

Form N-CSR FIDELITY CONCORD STREET For: Nov 30 - StreetInsider.com

Jan 22, 2025
pulisher
Jan 21, 2025

Verona Pharma stock target upgraded, retains buy on Q4 results - MSN

Jan 21, 2025
pulisher
Jan 15, 2025

symbol__ Stock Quote Price and Forecast - CNN

Jan 15, 2025
pulisher
Jan 13, 2025

Analyze Mereo Biopharma Group Plc ADR (NASDAQ: MREO) Before Investing. - Stocks Register

Jan 13, 2025
pulisher
Jan 12, 2025

Mereo BioPharma Provides Update on Lead Clinical Programs - GlobeNewswire Inc.

Jan 12, 2025
pulisher
Jan 12, 2025

Mereo BioPharma's Setrusumab Advances Phase 3 Trial as Alvelestat Gains Key EU Support - StockTitan

Jan 12, 2025
pulisher
Dec 17, 2024

How Are Things Looking For Mereo Biopharma Group Plc ADR (NASDAQ: MREO) For The Short Term? - Stocks Register

Dec 17, 2024
pulisher
Dec 16, 2024

Crude Oil Down 1%; Webuy Global Shares Spike Higher - Benzinga

Dec 16, 2024
pulisher
Dec 15, 2024

Mereo BioPharma's SWOT analysis: rare disease pipeline drives stock potential - Investing.com

Dec 15, 2024
pulisher
Nov 25, 2024

Mereo BioPharma's SWOT analysis: rare disease stock poised for growth - Investing.com

Nov 25, 2024
pulisher
Nov 01, 2024

European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading - MSN

Nov 01, 2024
pulisher
Sep 17, 2024

Mereo BioPharma CFO sells over $120k in company stock - Investing.com India

Sep 17, 2024
pulisher
Sep 16, 2024

Mereo BioPharma CFO sells over $121k in company stock - Investing.com

Sep 16, 2024
pulisher
Aug 19, 2024

Liquidia, Shake Shack And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga

Aug 19, 2024
pulisher
Aug 13, 2024

Mereo BioPharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

Aug 13, 2024
pulisher
Jun 16, 2024

Street calls of the week: Upgrade for Shopify; downgrades for AMD, Paramount - Investing.com

Jun 16, 2024
pulisher
May 15, 2024

Mereo BioPharma Reports First Quarter 2024 Financial Results and Provides Corporate Update - Yahoo Finance

May 15, 2024
pulisher
Mar 27, 2024

Mereo BioPharma Reports Full Year 2023 Financial Results and Provides Corporate Update - GlobeNewswire

Mar 27, 2024
pulisher
Feb 16, 2024

15 Top Performing European Stocks So Far in 2024 - Yahoo Finance

Feb 16, 2024
pulisher
Oct 23, 2023

Mereo BioPharma Reports on Recent Program Developments and Provides Financial Update - Yahoo Finance

Oct 23, 2023

Mereo Biopharma Group Plc Adr Stock (MREO) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$20.07
price up icon 0.15%
$69.51
price down icon 4.32%
$32.19
price down icon 1.26%
$25.22
price up icon 2.48%
$101.81
price up icon 3.09%
biotechnology ONC
$229.22
price down icon 0.76%
Cap:     |  Volume (24h):